Heart rate changes during halothane-tubocurarine anaesthesia (Group I, 60 patients), and pethidine-tubocurarine (Group II, 20 patients) have been studied. Significant changes were noted immediately after thiopentone induction, after intubation and after atropine 1.2 mg, 1.8 mg, or 3.0 mg. It was found that atropine 1.8 mg was as effective as atropine 3.0 mg in increasing heart rate, Atropine caused a similar degree of tachycardia in patients who were given halothane 1.5-2.0 per cent or pethidine 100-150 mg in incremental doses of 25 mg in addition to the inspired mixture of nitrous oxide 6 l./min and oxygen 3 L/min. Neostigmine 5 mg significantly reduced the heart rate irrespective of the preceding dose of atropine.
Anaesthetists differ in their views on the dose of atropine and neostigmine that should be used to reverse the neuromuscular block produced by tubocurarine. In the course of a study of heart rate changes during anaesthesia with and without halothane, the effects of thiopentone intubation and different doses of atropine preceding neostigmine 5 mg for reversing the action of tubocurarine were determined.
METHODS
Forty-nine females and 31 males whose ages ranged from 22 to 77 years (mean 47.5) and who were undergoing routine operations (table I) were studied. Premedication consisted of diazepam 10 mg i.m. 1 hour before anaesthesia. To induce anaesthesia thiopentone (2.5%) 200-500 mg was given intravenously, and was followed by suxamethonium 50 mg. The larynx and trachea were sprayed with 4% lignocaine solution and a cuffed endotracheal tube inserted. Anaesthesia was maintained with nitrous oxide 6 L/min and oxygen 3 l./min and the patients breathed spontaneously. After the skin had been incised, 60 patients received in addition 1.5-2% halothane (Group I) delivered from a Fluotec Mark HI vaporizer. In 20 patients (Group II) pethidine 25 mg i.v. was injected intermittently (total 100-150 mg) in addition to the nitrous oxide and oxygen mixture. No halothane or pethidine was administered after the start of the atropine injection. Muscle relaxation was-obtained by injecting tubocurarine 20-40 mg and the patients were ventilated using a Cape-Waine ventilator at a minute volume of 10 l./min
In the anaesthetic room a Cambridge-. ,ex.g. recorder was connected to ^' dj^p from lead II was recorded or! paper-Wore induction, immediately after induction, 1 minute after suxamethonium (muscle fasciculation completed), immediately after intubation, after skin incision and after the onset of curarization, each record lasting 30 sec. Further recordings were taken 15 min after instituting IPPR and at the start of the peritoneal closure.
At the end of surgery, curarization was reversed by injecting neostigmine 5 mg, 3 min after atropine had been given in doses of 1.2, 1.8 or 3.0 mg. Injections of atropine lasted 10 sec. The e.c.g. recording began at the start of the atropine injection and lasted for 25 min. Further e.c.g. recordings were taken at 2, 5, and 10 min after injection of neostigminc. Each record lasted 30 sec. The 60 patients in Group I were divided chronologically into three equal groups which received atropine in doses of 1.2 (a), 1.8 (b), and 3.0 mg (c) respectively. The first 10 patients of Group n were given atropine 1.8 mg (a) and the remaining 10 patients atropine 3.0 mg (b). IPPR was continued with nitrous oxide 6 L/min and oxygen 3 l./min throughout the period of reversal, and 10 min after the injection of neostigmine the patient was being given 100% oxygen. Heart rate was obtained by counting QRS complexes over 10-sec periods and multiplying by 6.
The purity of the atropine was proved by British Pharmacopoeia assay methods and paper chromatographic identification.
RESULTS
The mean heart rate rose significantly immediately after thiopentone injection compared with the preinduction value (table II) . At 1 minute after suxamethonium injection the heart rate was virtually un-TABLB II. Heart rate (beatsjmin). Pooled results of all patients showing heart rate change immediately after induction, 1 min after suxamethonium, immediately after intubation, and after skin incision. Measurements were made before giving halothane or pethidine.
changed, but then rose slightly but significantly immediately after intubation. On skin incision there was no significant change in rate. In both groups, the mean heart rate rose significantly 2 minutes after injection of atropine (table  III) , compared with pre-atxopine values. No initial slowing preceded the onset of tachycardia. Five minutes after injection of neostigmine 5 mg, the rate had fallen significantly and was lower still at 10 min. Only in Group I(b) did the heart rate differ significantly at these times from the pre-atropine value, but this value (95.4 beats/min) was significantly higher than the odier pre-atropine rates (P<0.001). In Group II, the rate had fallen to values insignificantly different from the pre-atropine values, 5 and 10 min after neostigmine 5 mg.
DISCUSSION
The heart rate which increased significantly immediately after thiopentone injection confirms a known effect of thiobarbiturates. Increases have been reported in healthy (Jones, Deutsch and Turndorf, 1961) and in poor risk patients (Dundee and Barron, 1962) . The mean increase of 12 beats/min, immediately after intubation, although statistically significant, could not be regarded as clinically significant in these patients who had no cardiovascular disease. Reflex sympathetic stimulation, hypoxia or hypercarbia can increase cardiac rate during intubation but these patients were preoxygenated, and ventilation of the lungs was normally assisted until spontaneous breathing was resumed after intubation.
Atropine produced significant increases in heart rate. This was also observed by Rosner, Kepes and Foldes (1971) who found that statistically significant tachycardia developed only in those patients in which atropine preceded the administration of neo-TABLE III. Heart rate (beats/min) before and 2 min after atropine and 5 and 10 min after neostigmine (5 mg) which was injected 3 min after atropine. stigmine. The absence of initial slowing before the tachycardia produced by atropine agrees with reports by Kemp and Morton (1962) and Farman (1967) . The final heart rates after atropine in both groups were similar. The increase in rate which was least in Group I(b) can be explained by the initial high pre-atropine heart rate. The difference between the pre-atropine values of I(b) and I(a), I(b) and I(c) was highly significant. In this study atropine did not cause a lesser tachycardia with halothane than with pethidine. This result differs from the report by Farman and Kennedy (1968) that patients given halothane showed smaller increases in heart rate after atropine. Atropine 1.8 mg was as effective as 3.0 mg in increasing the heart rate in both groups. Hydrolysis of atropine into inactive tropic add and respective alkaloid, has been suggested to account for unexpectedly small increases in heart rate after atropine injection (Gravenstein and Perkins, 1964) . No such breakdown could be demonstrated in either of the batches of atropine used in this study.
Group I(a)
Electrocardiographic paper recording could not be prolonged because of the cost and the circumstances of the clinical anaesthesia. It was considered unnecessary to delay a particular manoeuvre in order to obtain continuous recording.
Neostigmine decreased the heart rate to the same extent, irrespective of the preceding dose of atropine. Similar observations were made by Rosner, Kepes . and Foldes (1971) who reported that the mean decrease of heart rate was about the same when different doses of atropine and neostigmine were administered separately or combined. Hunter (1953) showed that cardiac slowing always followed administration of neostigmine regardless of the timing of atropine.
Six patients developed premature ventricular contractions and two showed pulsus bigeminus. These arrhythmias were transient and needed no specific therapy, being helped by hyperventilation (Riding and Robinson, 1961) and maintenance of oxygen tension (Baraka, 1968) during the reversal.
MODIFICATIONS DE LA FREQUENCE CARDIAQUE AU COURS D'ANESTHESIES PAR L"HALOTHANE: EFFETS DE DOSES VARIABLES D'ATROPINE ET DE NEOSTIGMINE

SOMMAIRE
Les modifications de la frequence cardiaque ont 6tit erudites au cours d'une anesthesie par I'halothane et la tubocurarine (serie de 60 malades, N° 1) et par la pethidine et la tubocurarine (serie de 20 malad-s, N° 2). Des modifications significatives ont 4t6 notees immediatement apres l'inductian .anesthesique au thiopentone, apres l'intubation et apres radministration de doses de 1,2 mg, 1,8 mg ou 3,0 mg d'atropine. On a trouvd que l'atropine administree a la dose de 1,8 mg etait aussi cfficnrr que l'atropine administree a la dose de 3,0 mg, en ce qui concerne l'augmentation de la frequence cardiaque. L'atropine a ddtermini l'apparition d'un dcgri de tachycardie smulaire chez les malades ayant recu de I'halothane a 1,5 ou 2,0% ou de la pithidine a 100 ou 150 mg, suivant une posologie croissante a partir de doses de 25 mg, en plus du milange inhal6 a base de 6 l. 
RESUMEN
Se estudiaron los cambios de la frecuenda cardiaca durante la anestesia con halothane-tubocuiarina (grupo I, 60 «nfennos) y petidina-tubocurarina (grupo II, 20 enfermos).
BRITISH JOURNAL OF ANAESTHESIA Se apredaron cambios significativos inmediatamente despues de la induction con tiopentona, despues de la intubation y tras la inyecdon de la dosis de 1,2 mg, 1,8 mg y 3,0 mg de atropina. Se observ6 que una dosis de atropina de 1,8 mg era tan efectiva respecto al aumento de la frecuenda cardiaca, como la dosis de 3 mg. La atropina causaba un grado similar de taquicardia en los patientes a los que se habfa administrado halothane al 1,5-2,0%, 6 100-150 mg de petidina en dosis fraccionadas de 25 mg, con adition de 6iido nitrosa 6 l./min. y oxigeno 3 l./min. a la mezcla inspirada. Una dosis de 5 mg de neostigmina reduda apredablemente la frecuenda cardiaca, en orden inverso a la dosis de atropina administrada previamente.
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